Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment

16 May 2024

Abstract excerpt

BACKGROUND: Migraine lacks biomarkers that can trace the biological pathways of the disease and predict the effectiveness of treatments. Monoclonal antibodies targeting calcitonin gene-related peptide pathway - including erenumab - offer the opportunity of investigating potential migraine biomarkers due to their specific mechanism of action in preventing both episodic (EM) and chronic (CM) migraine. Our study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related cognitive impairment studies
Share to Migraine and Headache Studies
Share to Vestibular and auditory disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38755568
DOI: 10.1186/s10194-024-01787-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNA profiling in women with migraine: effects of CGRP-targeting treatmentPMID 38755568Read ↗

Current Evidence on Potential Uses of MicroRNA Biomarkers for Migraine: From Diagnosis to TreatmentSemantic proximity Read ↗

The Role of MicroRNA in Migraine: A Systemic Literature ReviewSemantic proximity Read ↗

Unveiling the Efficacy and Safety of Erenumab, a Monoclonal Antibody Targeting Calcitonin Gene-related Peptide (CGRP) Receptor, in Patients with Chronic and Episodic Migraine: A GRADE-assessed Systematic Review and Meta-analysis of Randomized Clinical Trials with Subgroup AnalysisSemantic proximity Read ↗

Atogepant: Mechanism of action, clinical and translational scienceSemantic proximity Read ↗

A study of differential microRNA expression profile in migraine: the microMIG exploratory studySemantic proximity Read ↗

Different Doses of Erenumab for Preventive Treatment of Episodic Migraine: A Systematic Review and Network Meta-AnalysisSemantic proximity Read ↗

Efficacy and Safety of CGRP Monoclonal Antibodies for the Prevention of Migraine Compared with Placebo: A Systematic Review and Meta-AnalysisSemantic proximity Read ↗

Dynamic fluctuations of salivary CGRP levels during migraine attacks: association with clinical variables and phenotypic characterization.Semantic proximity Read ↗

Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – An updated systematic review and meta-analysisSemantic proximity Read ↗

Real-world experience of erenumab in patients with chronic or episodic migraine in the UAESemantic proximity Read ↗

Monoclonal Antibodies Against Calcitonin Gene-related Peptide for Migraine Prophylaxis: A Systematic Review of Real-world DataSemantic proximity Read ↗

Erenumab in highly therapy-refractory migraine patients First German Real-world evidenceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.